US RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
US RESEARCH ROUNDUP-Autodesk, Metlife, Rollins Nov 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Autodesk, Metlife and Rollins on Monday.
HIGHLIGHTS
* Allstate ALL.N: Piper Sandler cuts target price to $294 from $300 |
* Autodesk ADSK.O: Jefferies raises target price to $325 from $300 |
* Metlife MET.N: Piper Sandler raises target price to $115 from $110 |
* Rollins ROL.N: Citigroup raises to buy from neutral; raises PT to $49 from $32 |
* Vistra VST.N: CIBC cuts target price to $175 from $181 |
Following is a summary of research actions on US companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* 10X Genomics TXG.O: Barclays cuts target price to $70 from $110 |
* 10X Genomics TXG.O: J.P. Morgan cuts target price to $65 from $70 |
* Acadia Healthcare ACHC.O: Deutsche Bank raises PT to $46 from $32 |
* Acadia Healthcare ACHC.O: Raymond James raises PT to $43 from $39 |
* Adaptive Biotechnologies ADPT.O: J.P. Morgan raises PT to $35 from $30 |
* Advance Auto Parts AAP.N: Mizuho cuts target price to $50 from $58 |
* Advanced Drainage Systems WMS.N: Stephens cuts target price to $155 from $175 |
* Advanced Micro Devices AMD.O: Oppenheimer raises to outperform from perform |
* Aflac AFL.N: Mizuho raises target price to $112 from $107 |
* Aflac AFL.N: Piper Sandler raises target price to $143 from $138 |
* Airbnb ABNB.O: Jefferies raises target price to $230 from $215 |
* Albemarle ALB.N: Citigroup raises target price to $140 from $125 |
* Albemarle ALB.N: Deutsche Bank cuts target price to $125 from $155 |
* Albemarle ALB.N: Scotiabank cuts target price to $165 from $190 |
* Albemarle ALB.N: UBS cuts target price to $137 from $150 |
* Allstate ALL.N: Piper Sandler cuts target price to $294 from $300 |
* Ameren AEE.N: Mizuho raises target price to $123 from $113 |
* American Financial AFG.N: KBW raises target price to $150 from $147 |
* American Homes 4 Rent AMH.N: UBS raises target price to $34 from $32 |
* AMN Healthcare Services AMN.N: BMO raises target price to $52 from $43 |
* AMN Healthcare Services AMN.N: Truist Securities raises target price to $45 from $40 |
* Amrize AG AMRZ.N: Berenberg cuts to hold from buy; cuts target price to $46 from $48 |
* Apa APA.O: Gerdes Energy Research raises target price by $3 to $62 |
* Apa APA.O: Truist Securities raises target price to $50 from $45 |
* Applied Digital APLD.O: Morgan Stanley cuts target price to $25 from $41 |
* Applied Materials AMAT.O: B. Riley cuts target price to $475 from $700 |
* Ares Commercial Real Estate ACRE.N: Wells Fargo cuts target price to $3.5 from $5 |
* Ashland ASH.N: BMO raises target price to $81 from $75 |
* Assurant AIZ.N: Piper Sandler raises target price to $356 from $329 |
* Atmus Filtration Technologies ATMU.N: J.P. Morgan raises target price to $60 from $54 |
* Autodesk ADSK.O: Jefferies raises target price to $325 from $300 |
* Avient AVNT.N: Wells Fargo raises target price to $55 from $48 |
* Axon AXON.O: Barclays cuts target price to $507 from $688 |
* Axon AXON.O: Raymond James cuts target price to $475 from $675 |
* Banc of California BANC.N: Wells Fargo cuts target price to $21 from $22 |
* Bancorp TBBK.O: Piper Sandler cuts target price to $62 from $75 |
* Bankunited BKU.N: Wells Fargo cuts target price to $46 from $47 |
* Baxter International BAX.N: Barclays raises target price to $23 from $20 |
* Berkshire Hathaway BRKa.N: KBW raises target price to $765,000 from $735,000 |
* Beta Technologies BETA.N: Jefferies cuts to hold from buy; cuts PT to $27 from $29 |
* Bill BILL.N: Mizuho raises target price to $50 from $43 |
* Bioage Labs BIOA.O: Piper Sandler cuts target price to $40 from $73 |
* Biodesix BDSX.O: H.C. Wainwright cuts target price to $34 from $38 |
* Biogen BIIB.O: Piper Sandler raises target price to $305 from $245 |
* Bkv BKV.N: Gerdes Energy Research cuts target price by $4 to $24 |
* Black Rock Coffee Bar BRCB.O: Stifel resumes coverage with hold rating; PT $12 |
* BlackRock TCP Capital TCPC.O: Wells Fargo raises target price to $4.5 from $4 |
* Box BOX.N: D.A. Davidson raises target price to $60 from $50 |
* Box BOX.N: RBC raises target price to $35 from $26 |
* Brinker International EAT.N: Argus Research cuts target price to $240 from $280 |
* Brookdale Senior Living BKD.N: Stephens cuts target price to $12 from $17 |
* Brookfield Asset Management BAM.N: Piper Sandler raises PT to $52 from $49 |
* Brookfield Asset Management BAM.N: Scotiabank raises PT to $60.5 from $59 |
* Camping World CWH.N: Wells Fargo initiates coverage with overweight rating |
* Camping World CWH.N: Wells Fargo initiates coverage with target price $6 |
* Cardinal Health CAH.N: TD Cowen raises target price to $304 from $280 |
* Cargurus CARG.O: Barclays raises target price to $41 from $38 |
* Cava Group CAVA.N: Mizuho cuts target price to $54 from $56 |
* Celcuity CELC.O: H.C. Wainwright cuts target price to $150 from $155 |
* Cerebras Systems CBRS.O: Rosenblatt Securities cuts PT to $170 from $300 |
* Cerebras Systems CBRS.O: Wedbush cuts target price to $190 from $290 |
* CF Industries CF.N: RBC raises target price to $125 from $115 |
* Cg Oncology CGON.O: Wedbush raises target price to $84 from $80 |
* Charter Communications CHTR.O: Stonex cuts target price to $200 from $380 |
* Charter Communications CHTR.O: TD Cowen cuts target price to $345 from $372 |
* Charter Communications CHTR.O: Wells Fargo raises target price to $103 from $101 |
* Chesapeake Utilities CPK.N: Mizuho raises target price to $155 from $150 |
* Cigna CI.N: Barclays raises target price to $320 from $310 |
* Cigna CI.N: Leerink Partners raises target price to $315 from $300 |
* Cipher Digital CIFR.O: Morgan Stanley cuts target price to $27.50 from $51.50 |
* Cogent Biosciences COGT.O: H.C. Wainwright raises target price to $56 from $55 |
* Cohu COHU.O: B. Riley cuts target price to $60 from $75 |
* Commerce Bancshares CBSH.O: Wells Fargo cuts target price to $60 from $61 |
* Compass COMP.N: Deutsche Bank cuts target price to $13 from $15 |
* Concentra Group Holdings Parent CON.N: Mizuho raises PT to $47 from $40 |
* Conocophillips COP.N: Gerdes Energy Research raises target price by $2 to $160 |
* Conocophillips COP.N: Truist Securities raises target price to $142 from $136 |
* Consensus Cloud Solutions CCSI.O: Oppenheimer raises target price to $50 from $40 |
* Construction Partners ROAD.O: B. Riley cuts target price to $100 from $135 |
* Coreweave CRWV.O: Rosenblatt Securities cuts target price to $160 from $250 |
* Coreweave CRWV.O: Wells Fargo cuts target price to $115 from $160 |
* Corning GLW.N: Bernstein cuts target price to $120 from $140 |
* Coty COTY.N: Barclays raises target price to $3 from $2 |
* Coty COTY.N: Deutsche Bank raises target price to $4 from $3 |
* Crowdstrike CRWD.O: Bernstein raises target price to $177 from $132 |
* Cummins CMI.N: Barclays cuts target price to $600 from $675 |
* Curtiss-Wright CW.N: Piper Sandler cuts target price to $544 from $586 |
* Curtiss-Wright CW.N: Stifel cuts target price to $472 from $518 |
* Dauch DCH.N: Deutsche Bank cuts target price to $7 from $8 |
* Delek US Holdings DK.N: Raymond James cuts target price to $95 from $100 |
* Devon Energy DVN.N: J.P. Morgan raises target price to $68 from $65 |
* Devon Energy DVN.N: Susquehanna cuts target price to $60 from $63 |
* Devon Energy DVN.N: Truist Securities raises target price to $62 from $61 |
* Draftkings DKNG.O: Canaccord Genuity cuts target price to $30 from $40 |
* Draftkings DKNG.O: Deutsche Bank cuts target price to $22 from $28 |
* Draftkings DKNG.O: J.P. Morgan cuts to neutral from overweight; cuts PT to $21 from $30 |
* Draftkings DKNG.O: Mizuho cuts target price to $35 from $45 |
* Draftkings DKNG.O: Needham cuts target price to $25 from $30 |
* Draftkings DKNG.O: Northland Capital cuts target price to $20 from $28 |
* Draftkings DKNG.O: Stifel cuts to hold from buy; cuts target price to $21 from $32 |
* Draftkings DKNG.O: Truist Securities cuts target price to $22 from $26 |
* Draftkings DKNG.O: Barclays cuts target price to $27 from $34 |
* Duke Energy DUK.N: Mizuho raises target price to $140 from $136 |
* Duolingo DUOL.O: Jefferies raises target price to $175 from $145 |
* Dupont DD.N: BMO raises target price to $190 from $186 |
* Dutch Bros BROS.N: Stifel resumes coverage with buy rating; target price $48 |
* Dxp Enterprises DXPE.O: Stephens cuts target price to $200 from $220 |
* East West Bancorp EWBC.O: Wells Fargo raises target price to $155 from $150 |
* Eli Lilly LLY.N: Jefferies raises target price to $1700 from $1610 |
* Emerson EMR.N: BMO raises target price to $181 from $175 |
* EOG Resources EOG.N: J.P. Morgan raises target price to $170 from $164 |
* EOG Resources EOG.N: Truist Securities raises target price to $166 from $160 |
* EOG Resources EOG.N: UBS raises target price to $190 from $186 |
* Estee Lauder EL.N: Deutsche Bank raises target price to $128 from $124 |
* Eupraxia Pharmaceuticals EPRX.O: RBC initiates coverage with outperform rating; PT $14 |
* Evercommerce EVCM.O: Barclays cuts target price to $8.5 from $10 |
* Evergy EVRG.O: BMO raises target price to $94 from $89 |
* Evergy EVRG.O: Mizuho raises target price to $91 from $85 |
* Everquote EVER.O: Raymond James raises target price to $32 from $28 |
* Expedia Group EXPE.O: Jefferies cuts target price to $325 from $350 |
* Faeth Therapeutics FTH.O: Leerink Partners raises target price to $52 from $46 |
* Fair Isaac Corporation FICO.N: Mizuho cuts target price to $901 from $986 |
* Fidelity National Financial FNF.N: Barclays raises target price to $49 from $47 |
* Figure Technology Solutions FIGR.O: KBW cuts target price to $37 from $45 |
* First Ban FBP.N: Wells Fargo cuts target price to $30 from $32 |
* First Horizon FHN.N: Wells Fargo raises target price to $26 from $25 |
* First Interstate Bancsystem FIBK.O: Wells Fargo raises target price to $36 from $34 |
* First Solar FSLR.O: Piper Sandler cuts target price to $222 from $251 |
* Fluor FLR.N: Truist Securities cuts target price to $62 from $71 |
* Forbright FRBT.O: Wells Fargo raises target price to $22 from $21 |
* Formfactor FORM.O: B. Riley cuts target price to $125 from $150 |
* Fox FOXA.O: Seaport Research Partners raises to buy from neutral |
* Franklin Resources BEN.N: Barclays raises target price to $36 from $34 |
* Franklin Resources BEN.N: Deutsche Bank raises target price to $35 from $34 |
* Galaxy Digital GLXY.O: Morgan Stanley cuts target price to $27 from $43 |
* Generac GNRC.N: Piper Sandler cuts target price to $266 from $279 |
* Global Payments GPN.N: Barclays raises target price to $97 from $89 |
* Globalfoundries GFS.O: Argus Research cuts target price to $70 from $90 |
* Globus Medical GMED.N: Truist Securities cuts target price to $90 from $100 |
* Graham GHM.N: William Blair initiates coverage with outperform rating |
* Haemonetics HAE.N: Raymond James raises target price to $144 from $125 |
* Helios Technologies HLIO.N: Stifel cuts target price to $65 from $78 |
* Hilton Worldwide HLT.O: BMO raises target price to $385 from $360 |
* Hmh Holding HMH.O: Piper Sandler cuts target price to $26 from $32 |
* Humana HUM.N: Barclays raises target price to $587 from $582 |
* Humana HUM.N: Deutsche Bank raises target price to $516 from $436 |
* Humana HUM.N: Leerink Partners raises target price to $583 from $513 |
* Humana HUM.N: Piper Sandler raises target price to $526 from $463 |
* Hut 8 Mining HUT.O: Morgan Stanley cuts target price to $184 from $275 |
* Iambic Therapeutics IAM.O: Citigroup initiates coverage with buy rating; PT $22 |
* Iambic Therapeutics IAM.O: J.P. Morgan starts coverage with overweight rating; PT $22 |
* Iambic Therapeutics IAM.O: BofA Global Research initiates with buy rating |
* Iambic Therapeutics IAM.O: BofA Global Research initiates with price objective $30 |
* Icf International ICFI.O: Truist Securities raises target price to $90 from $80 |
* Ichor ICHR.O: D.A. Davidson assumes coverage with buy rating |
* Ichor ICHR.O: D.A. Davidson assumes coverage with price target $37 vs $85 |
* Ichor ICHR.O: B. Riley cuts target price to $60 from $70 |
* Immunovant IMVT.O: Piper Sandler cuts target price to $50 from $66 |
* Installed Building Products IBP.N: Stephens raises target price to $230 from $200 |
* Installed Building Products IBP.N: Stifel cuts to hold from buy; ups PT to $225 from $220 |
* Insulet PODD.O: Truist Securities raises target price to $160 from $153 |
* IRhythm IRTC.O: Citigroup cuts to neutral from buy; cuts PT to $124 from $157 |
* IRhythm IRTC.O: Truist Securities cuts target price to $140 from $168 |
* ITT ITT.N: Stifel raises target price to $259 from $256 |
* Jazz Pharmaceuticals JAZZ.O: Bernstein cuts target price to $220 from $229 |
* Kailera Therapeutics KLRA.O: Canaccord Genuity initiates coverage with buy rating |
* Kailera Therapeutics KLRA.O: Canaccord Genuity initiates coverage with PT $44 |
* Karman KRMN.N: Barclays raises target price to $80 from $79 |
* Karman KRMN.N: Raymond James cuts target price to $75 from $100 |
* Kayne Anderson BDC KBDC.N: Wells Fargo cuts target price to $13 from $14 |
* Kayne Anderson BDC KBDC.N: UBS cuts target price to $12.50 from $13.50 |
* Kimberly-Clark KMB.O: Deutsche Bank raises target price to $115 from $107 |
* Kimberly-Clark KMB.O: Barclays raises target price to $112 from $106 |
* Kinetik KNTK.N: Wells Fargo raises target price to $56 from $54 |
* Koppers KOP.N: B. Riley cuts target price to $54 from $62 |
* Kratos Defense & Security Solutions KTOS.O: Canaccord Genuity cuts PT to $120 from $135 |
* Kratos Defense & Security Solutions KTOS.O: Raymond James cuts PT to $90 from $144 |
* Kratos Defense & Security Solutions KTOS.O: UBS cuts target price to $46 from $60 |
* L3Harris Technologies LHX.N: Citigroup resumes coverage with buy rating; PT $348 |
* Lam Research LRCX.O: B. Riley cuts target price to $310 from $338 |
* Lsi Industries LYTS.O: Oppenheimer cuts target price to $27 from $29 |
* Lumentum LITE.O: Bernstein cuts target price to $635 from $900 |
* Main Street Capital MAIN.N: UBS raises target price to $58 from $57 |
* Marvell Technology MRVL.O: B. Riley cuts target price to $250 from $275 |
* Mastec MTZ.N: Piper Sandler cuts target price to $269 from $313 |
* Mattel MAT.O: Citigroup cuts target price to $15 from $17 |
* Mercury General MCY.N: Raymond James cuts PT to $100 from $120 |
* Metlife MET.N: Mizuho raises target price to $112 from $109 |
* Metlife MET.N: Piper Sandler raises target price to $115 from $110 |
* Mettler Toledo MTD.N: Barclays raises target price to $1,900 from $1,700 |
* Mettler-Toledo MTD.N: Jefferies raises target price to $1,930 from $1,580 |
* Mettler-Toledo MTD.N: J.P. Morgan raises target price to $1,725 from $1,550 |
* Mettler-Toledo MTD.N: RBC raises target price to $1,790 from $1,515 |
* Mettler-Toledo MTD.N: Stifel raises target price to $1,900 from $1,600 |
* Microchip Technology MCHP.O: Barclays cuts target price to $90 from $105 |
* Moderna MRNA.O: Jefferies raises target price to $230 from $200 |
* Moderna MRNA.O: Piper Sandler raises target price to $305 from $230 |
* Moderna MRNA.O: RBC raises target price to $145 from $130 |
* Moderna MRNA.O: TD Cowen raises target price to $110 from $90 |
* Molson Coors Beverage TAP.N: Barclays raises target price to $40 from $36 |
* Molson Coors Beverage TAP.N: J.P. Morgan cuts target price to $37 from $41 |
* Molson Coors Beverage TAP.N: J.P. Morgan cuts to underweight from neutral |
* Monster Beverage MNST.O: Deutsche Bank cuts target price to $47 from $49 |
* Mp Materials MP.N: Canaccord Genuity cuts target price to $70 from $82 |
* Mp Materials MP.N: Barclays cuts target price to $54 from $65 |
* Msa Safety MSA.N: D.A. Davidson cuts target price to $216 from $223 |
* Nelnet NNI.N: TD Cowen raises target price to $135 from $125 |
* Nextpower NXT.O: Piper Sandler raises target price to $115 from $110 |
* Norwood Financial NWFL.O: Stephens cuts target price to $37 from $35 |
* Nutex Health NUTX.O: B. Riley raises target price to $357 from $325 |
* OFG Bancorp OFG.N: Wells Fargo cuts target price to $53 from $55 |
* Oklo OKLO.N: Canaccord Genuity cuts target price to $66 from $100 |
* Oklo OKLO.N: HSBC cuts target price to $38 from $70 |
* Old National Bancorp ONB.O: Wells Fargo cuts target price to $29 from $30 |
* Onto Innovation ONTO.N: B. Riley cuts target price to $285 from $340 |
* Ormat Technologies ORA.N: Piper Sandler cuts target price to $120 from $142 |
* Oshkosh OSK.N: Raymond James cuts target price to $165 from $170 |
* Owens Corning OC.N: Jefferies cuts target price to $145 from $165 |
* Pacific Biosciences of California PACB.O: UBS cuts target price to $2.70 from $3.05 |
* Parabilis Medicines PBLS.O: Canaccord Genuity initiates coverage with buy rating |
* Parabilis Medicines PBLS.O: Canaccord Genuity initiates coverage with PT $39 |
* Patrick Industries PATK.O: Wells Fargo initiates coverage with overweight rating |
* Patrick Industries PATK.O: Wells Fargo initiates coverage with target price $95 |
* Paylocity Holding Corp PCTY.O: TD Cowen raises target price to $205 from $178 |
* PJT Partners PJT.N: BMO raises target price to $175 from $160 |
* Popular BPOP.O: Wells Fargo cuts target price to $190 from $195 |
* Portillos PTLO.O: UBS raises target price to $7 from $4.5 |
* Primo Brands PRMB.N: Barclays raises target price to $29 from $26 |
* Primoris Services PRIM.N: Piper Sandler cuts target price to $80 from $90 |
* Procore Technologies PCOR.N: Jefferies raises target price to $105 from $75 |
* Qnity Electronics Q.N: RBC cuts target price to $152 from $160 |
* Quanta Services PWR.N: Piper Sandler cuts target price to $701 from $714 |
* Rb Global RBA.N: Stephens cuts target price to $103 from $111 |
* Reinsurance Group of America RGA.N: Piper Sandler ups PT to $300 from $274 |
* Relay Therapeutics RLAY.O: Jonestrading raises target price to $31 from $20 |
* Riot Platforms RIOT.O: Morgan Stanley raises target price to $41 from $35.5 |
* Rogers ROG.N: B. Riley cuts target price to $180 from $195 |
* Rollins ROL.N: Citigroup raises to buy from neutral; raises PT to $49 from $32 |
* Rollins ROL.N: Wells Fargo raises target price to $30 from $26 |
* Semtech SMTC.O: B. Riley cuts target price to $190 from $210 |
* Six Flags Entertainment FUN.N: JP Morgan cuts target price to $12 from $22 |
* Snap SNAP.N: HSBC cuts target price to $5.42 from $6 |
* Starbucks SBUX.O: Stifel resumes coverage with buy rating; target price $115 |
* Supernus SUPN.O: BofA Global Research initiates with buy rating; price objective $47 |
* Sylvamo SLVM.N: Truist Securities raises target price to $47 from $40 |
* Tango Therapeutics TNGX.O: Wedbush cuts target price to $40 from $45 |
* Targa Resources TRGP.N: Jefferies cuts target price to $311 from $326 |
* Targa Resources TRGP.N: Wells Fargo raises target price to $330 from $324 |
* Target TGT.N: BofA Global Research raises price objective to $141 from $140 |
* Teleflex TFX.N: Truist Securities raises target price to $167 from $142 |
* Terawulf WULF.O: Needham cuts target price to $25 from $33 |
* Terawulf WULF.O: Rosenblatt Securities cuts target price to $20 from $30 |
* The Hanover Insurance THG.N: KBW raises target price to $248 from $223 |
* Thor Industries THO.N: Wells Fargo initiates coverage with equal weight rating |
* Thor Industries THO.N: Wells Fargo initiates coverage with target price $80 |
* T-Mobile TMUS.O: Argus Research cuts target price to $220 from $245 |
* Transmedics TMDX.O: UBS raises target price to $88 from $77 |
* Treace Medical Concepts TMCI.O: Stifel raises to buy from hold; ups PT to $6.5 from $4.5 |
* Trex TREX.N: Stifel raises target price to $62 from $55 |
* Trimble TRMB.O: Barclays cuts target price to $78 from $80 |
* Tripadvisor TRIP.O: Jefferies raises to hold from underperform; cuts PT to $7 from $8 |
* Tronox TROX.N: J.P. Morgan raises to neutral from underweight |
* Trupanion TRUP.O: Stifel raises target price to $34 from $29 |
* Uber UBER.N: Citigroup resumes coverage with buy rating; price target $105 |
* Ubiquiti UI.N: Barclays raises target price to $537 from $489 |
* Ufp Industries UFPI.O: Stifel cuts target price to $80 from $85 |
* United Therapeutics UTHR.O: H.C. Wainwright assumes coverage with buy rating; PT $660 |
* Unity Software U.N: BofA Global Research raises price objective to $65 from $50 |
* Unity Software U.N: Deutsche Bank raises target price to $70 from $50 |
* Unum UNM.N: J.P. Morgan raises to overweight from neutral |
* Unum UNM.N: J.P. Morgan ups PT to $90 from $98 |
* USA Today TDAY.N: Citigroup raises to buy from neutral; ups PT to $8.95 from $7.20 |
* Veeva Systems VEEV.N: BMO raises target price to $300 from $270 |
* Veeva Systems VEEV.N: BTIG raises target price to $360 from $340 |
* Veeva Systems VEEV.N: Canaccord Genuity raises target price to $315 from $260 |
* Veeva Systems VEEV.N: Truist Securities raises target price to $360 from $305 |
* Vera Therapeutics VERA.O: Raymond James raises target price to $87 from $84 |
* Veracyte VCYT.O: UBS cuts target price to $35 from $65 |
* Veradermics MANE.N: Leerink Partners raises target to $150 from $135 |
* Vericel VCEL.O: Truist Securities raises target price to $65 from $52 |
* Viasat VSAT.O: Deutsche Bank raises target price to $125 from $97 |
* Viasat VSAT.O: J.P. Morgan cuts target price to $120 from $130 |
* Viasat VSAT.O: Needham cuts target price to $85 from $105 |
* Vistra VST.N: CIBC cuts target price to $175 from $181 |
* Vse VSEC.O: Jefferies cuts target price to $245 from $275 |
* Vse VSEC.O: Deutsche Bank raises target price to $230 from $229 |
* Vulcan Materials VMC.N: Stifel raises target price to $342 from $320 |
* Walmart WMT.O: UBS raises target price to $149 from $130 |
* Watts Water Technologies WTS.N: Stifel cuts target price to $430 from $445 |
* Wayfair W.N: Citigroup raises target price to $145 from $133 |
* Welltower WELL.N: BMO raises target price to $275 from $270 |
* Western Alliance Bancorporation WAL.N: Wells Fargo cuts target price to $82 from $84 |
* Westlake WLK.N: BMO cuts target price to $75 from $81 |
* Westlake WLK.N: Truist Securities cuts target price to $81 from $90 |
* Winnebago WGO.N: Wells Fargo initiates coverage with target price $27 |
* Winnebago WGO.N: Wells Fargo initiates coverage with underweight rating |
* Wintrust Financial WTFC.O: Wells Fargo raises PT to $165 from $160 |
* Zillow ZG.O: Keybanc cuts to sector weight from overweight |
* Zimmer Biomet ZBH.N: Barclays raises target price to $115 from $100 |
* Zimmer Biomet ZBH.N: Leerink Partners raises target price to $110 from $97 |
(Compiled by Bengaluru Newsroom; Editing by Perla Velasco)
((Diaries@thomsonreuters.com))
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova